Welcome Guest | Register / Login

Impact on Publicly Traded Bio/Pharma Companies - Coronavirus Disease (COVID-19) 2019 Impact Report

Table of Contents
1. Market Cap Change for Bio/Pharma Companies in Q1 2020
Market Cap for Bio/Pharma Companies With and Without a COVID-19 Drug over Q1 2020
Q1 2020 Change in Market Cap by Company Market Cap Size
2. Market Cap for Top 20 Bio/Pharma Companies: Q1 2020 vs. 2019
Market Cap Change for Top 20 Bio/Pharma: Q1 2020 vs. 2019
Market Cap Change Q1 2020: Bayer AG
Market Cap Change Q1 2020: Gilead Sciences
Market Cap Change Q1 2020: Regeneron Pharmaceuticals
Q1 2020 Market Cap Change for Top 20 Bio/Pharma: With and Without a COVID-19 Drug
Market Cap Growth: Q1 2020 vs. 2019 Biggest Movers
Market Cap Change Q1 2020: AbbVie Inc
3. Drug Sales for Top 20 Bio/Pharma Companies vs. Market Cap
Global Total Drug Sales for Q1 2020 vs. Market Cap
4. Drug Sales for Top 20 Bio/Pharma Companies Q1 2020 vs. Q4 2019
Global Total Drug Sales Q1 2020 vs. Q4 2019
5. Drug Sales for Top 20 Bio/Pharma Companies vs. Archived Forecasts
Q1 2020 Actual Sales vs. Archived Global Analyst Consensus Sales Forecast for Top-Selling Drugs
Total Q1 2020 Actual Sales vs. Total Archived Global Analyst Consensus Sales Forecast
Key Findings
Appendix
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy